Asto E, Mendez I, Audivert S, Farran-Codina A, Espadaler J
However, there are still many controversies regarding the tolerability and adverse reactions of GLP-1RAs in the treatment of diabetes
Another large study, the FLOW trial, is ongoing and directly studies the link between Semaglutide and CKD
By managing how the body processes sugar and encouraging feelings of fullness, GLP-1 drugs for weight loss allow individuals to make more confident lifestyle choices
However, more data are needed to assess whether gastric emptying will be more affected by GLP1RAs in patients with pre-exposure gastric motility disorders, and whether it might result in clinically significant PK changes
Natural alternatives may prove to be more accessible and less expensive